中信证券股份有限公司 关于江苏康众数字医疗科技股份有限公司股东 向特定机构投资者询价转让股份 相关资格的核查意见 广东省深圳市福田区中心三路 8 号卓越时代广场（二期）北座 1 中信证券股份有限公司（以下简称"中信证券"）受江苏康众数字医疗科技 股份有限公司（以下简称"康众医疗"）股东苏州康诚企业管理咨询服务有限公 司、宁波梅山保税港区同驰投资管理合伙企业（有限合伙）（以下合称"出让方"） 委托，组织实施本次康众医疗首发前股东向特定机构投资者询价转让（以下简称 "本次询价转让"）。 根据《关于在上海证券交易所设立科创板并试点注册制的实施意见》《科创 板上市公司持续监管办法（试行）》《上海证券交易所科创板股票上市规则（2025 年 4 月修订）》《上海证券交易所科创板上市公司自律监管指引第 4 号——询价 转让和配售（2025 年 3 月修订）》（以下简称"《询价转让和配售指引》"）等 相关规定，中信证券对参与本次询价转让股东的相关资格进行核查，并出具本核 查意见。 1、苏州康诚企业管理咨询服务有限公司 | 企业名称 | 苏州康诚企业管理咨询服务 | 统一社会信用代 | 91320594553764158M | ...

Core Points - The shareholders of Kangzhong Medical (688607.SH) plan to transfer a total of 4.7 million shares, which represents 5.33% of the company's total share capital [1] Summary by Category Share Transfer - The share transfer will not be conducted through the secondary market, and the transferee is prohibited from transferring the shares within six months after the acquisition [1]

Core Points - Kangzhong Medical announced a share transfer plan involving Suzhou Kangcheng Enterprise Management Consulting Co., Ltd. and Ningbo Meishan Free Trade Port Zone Tongchi Investment Management Partnership (Limited Partnership) [1] - A total of 4.7 million shares, representing 5.33% of the company's total equity, will be transferred [1] - The transfer will not occur through centralized bidding or block trading, and the transferee must be an institutional investor with appropriate pricing capability and risk tolerance [1] - The minimum transfer price will not be lower than 70% of the average stock trading price over the 20 trading days prior to the issuance of the subscription invitation on October 27, 2025 [1] - The transferee is prohibited from transferring the shares within six months after the acquisition [1]

Core Viewpoint - The A-share semiconductor sector has experienced a significant rally, with multiple stocks reaching their daily limit up or showing substantial gains [1] Group 1: Stock Performance - Purun Co., Ltd. hit the daily limit up of 20% [1] - Shenkong Co., Ltd. increased by over 11% [1] - Huahong Technology rose by over 10% [1] - Huiding Technology reached a daily limit up of 10% [1] - Mingwei Electronics gained 9% [1] - Lianyun Technology, Jucheng Co., Ltd., and Xinxiangwei increased by over 8% [1] - Baiwei Storage and Galaxy Microelectronics rose by over 7% [1] - Beijing Junzheng and Huahai Chengke increased by over 6% [1] - Jinghe Integration, Weicet Technology, Hengsuo Co., Ltd., Jingyi Equipment, and Lanke Technology rose by over 5% [1]

Core Insights - The company reported a revenue of 81,136,819.16 yuan for Q3 2025, representing a year-on-year growth of 21.80% [2] - The net profit attributable to shareholders of the listed company was 1,087,381.54 yuan, showing a significant year-on-year decline of 79.36% [2] Financial Performance - Revenue for Q3 2025: 81.14 million yuan, up 21.80% year-on-year [2] - Net profit for Q3 2025: 1.09 million yuan, down 79.36% year-on-year [2]

Core Viewpoint - The article summarizes significant announcements from various listed companies in the Shanghai and Shenzhen stock markets, highlighting potential investment opportunities and risks based on recent developments and financial performance. Group 1: Company Announcements - Tianpu Co., Ltd. warns that its stock price has significantly deviated from its fundamentals, with a cumulative increase of 246.02% from August 22 to October 22, indicating a potential for rapid decline [4] - Shenzhen Sanda A plans to sell stakes in several subsidiaries to focus on its core business, including 80% of Zhongdian Continental Environmental Technology [5][6] - Zhongchong Co., Ltd. received an administrative regulatory measure from the Shandong Securities Regulatory Bureau for failing to announce a significant change in shareholding [7] - Construction Machinery has reported a net loss of 447 million yuan for the first half of 2025, marking three consecutive years of losses [8] - Junshi Biosciences announced that its subsidiary passed a recent FDA inspection, indicating compliance with CGMP standards [9] Group 2: Financial Performance - Duofuduo reported a net profit increase of 407.74% year-on-year for the first three quarters of 2025, with a revenue of 6.73 billion yuan [17] - Weihuaxincai achieved a net profit growth of 250.04% year-on-year in Q3, with revenues of 660 million yuan [18] - Guangdong Jianke reported a net profit increase of 190.62% year-on-year for the first three quarters, despite a revenue decline [19] - Xianggang Technology reported a net profit increase of 186.19% year-on-year for the first three quarters, with revenues of 742 million yuan [20] - Defu Technology reported a net profit increase of 132.63% year-on-year for the first three quarters, driven by increased copper foil sales [21] Group 3: Major Transactions and Investments - Tangrenshen plans to establish two investment funds with a total investment of 11.04 million yuan to focus on the agricultural sector [13] - Farsen intends to sell a 10% stake in Bekaert Steel Cord, constituting a major asset restructuring [14] - Shikong Technology plans to acquire 100% of Jiahe Jingwei, entering the storage sector [15] - Jiangsu New Energy's controlling shareholder is investing in offshore wind power projects and will manage the project companies [11][12] Group 4: Shareholder Actions - Qianyuan Pharmaceutical's shareholder plans to reduce its stake by up to 3% [42] - Zhengfan Technology's board members plan to collectively reduce their holdings by up to 1.88% [43]

Core Insights - The company reported a revenue of 226 million yuan for the first three quarters of 2025, representing a year-on-year increase of 15.61% [1] - The net profit attributable to shareholders was 348,000 yuan, showing a significant decline of 97.24% year-on-year [1] - The company experienced a substantial drop in its net profit margin, with a net profit margin of 0.05%, down 6.39 percentage points from the previous year [2] Financial Performance - The gross profit margin for the first three quarters of 2025 was 38.03%, a decrease of 4.87 percentage points year-on-year [2] - The company reported a basic earnings per share of 0.00 yuan and a weighted average return on equity of 0.01% [2] - The third quarter of 2025 saw a gross profit margin of 36.49%, down 10.14 percentage points year-on-year and 4.45 percentage points quarter-on-quarter [2] Expense Analysis - Total operating expenses for the third quarter were 79.55 million yuan, an increase of 4.75 million yuan compared to the same period last year [2] - The expense ratio was 35.20%, a decrease of 3.06 percentage points year-on-year [2] - Sales expenses decreased by 0.87%, while management expenses increased by 41.78% [2] Shareholder Information - As of the end of the third quarter of 2025, the total number of shareholders was 4,861, an increase of 101 from the end of the first half of the year [2] - The average market value per shareholder rose from 347,100 yuan to 498,000 yuan, an increase of 43.46% [2] Company Overview - Jiangsu Kangzhong Digital Medical Technology Co., Ltd. specializes in the research, production, sales, and service of digital X-ray flat panel detectors [3] - The main revenue source is from flat panel detector sales, accounting for 96.41% of total revenue [3] - The company is classified under the pharmaceutical and biological industry, specifically in medical devices [3]

Core Points - Kangzhong Medical (688607) reported a revenue of 226 million yuan for the first three quarters of 2025, representing a year-on-year increase of 15.61% [1] - The net profit attributable to the parent company was 348,000 yuan, showing a significant year-on-year decline of 97.24% [1] - The company attributed the decline in performance to reduced investment income from trading financial assets and specific provisions for bad debts [1]

Core Viewpoint - Kangzhong Medical reported its third-quarter results, showing a significant increase in revenue but a drastic decline in net profit [1] Financial Performance - The company's revenue for the first three quarters reached 226,019,950.40 yuan, representing a year-on-year increase of 15.61% [1] - The net profit attributable to shareholders of the listed company was 347,982.91 yuan, reflecting a year-on-year decrease of 97.24% [1] Shareholder Changes - Among the top ten circulating shareholders, new entrants include Changcheng Limited, Shanghai Calculus Private Fund Management Co., Ltd. - Calculus No. 3 Private Securities Investment Fund, and Zhu Yongfang [1]

Core Insights - The company reported a third-quarter revenue of 81.1368 million yuan, representing a year-on-year increase of 21.8% [1] - The net profit for the third quarter was 1.0874 million yuan, showing a significant year-on-year decline of 79.36% [1] - For the first three quarters of 2025, the company achieved a revenue of 226 million yuan, which is a year-on-year growth of 15.61% [1] - The net profit for the first three quarters was 348,000 yuan, reflecting a substantial year-on-year decrease of 97.24% [1] - The performance fluctuations are primarily attributed to reduced investment income from trading financial assets and specific provisions for bad debts [1]